Clinical trial
Population Pharmacokinetics of the Nucleoside Analogues Clofarabine and Fludarabine in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (alloHCT)
NCT03609814 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Population Pharmacokinetics of the Nucleoside Analogues Clofarabine and Fludarabine in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (alloHCT)
- Lead sponsor
- University of California, San Francisco
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 26, 2016
- Completion date
- June 30, 2020
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fanconi's anemia, genetic inborn errors of metabolism, hematologic malignancies, hemoglobinopathies, immunodeficiencies, nonmalignant diseases, sickle cell disease, thalassemia